Human MAIT cells are devoid of alloreactive potential: prompting their use as universal cells for adoptive immune therapy.
Marie TourretNana Talvard-BallandMarion LambertGhada Ben YoussefMathieu F ChevalierArmelle BohineustThomas YvorraFlorence MorinSaba AzarnoushOlivier LantzJean-Hugues DalleSophie Caillat-ZucmanPublished in: Journal for immunotherapy of cancer (2022)
ClinicalTrials.gov number NCT02403089.